Stay updated on APL-2 vs Sham in GA: Clinical Trial
Sign up to get notified when there's something new on the APL-2 vs Sham in GA: Clinical Trial page.

Latest updates to the APL-2 vs Sham in GA: Clinical Trial page
- Check7 days agoChange DetectedNo significant changes to core study content (inclusion/exclusion criteria, primary/secondary outcomes, or enrollment) were observed between screenshots; any differences appear to be minor UI/layout adjustments that do not affect the information on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check43 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdated to revision v3.0.2 and removed the 'Back to Top' element. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check72 days agoChange DetectedThe web page has been updated to include specific facility names and locations, as well as new publications related to pegcetacoplan and geographic atrophy. The previous version's general location terms and related topics have been removed.SummaryDifference9%

Stay in the know with updates to APL-2 vs Sham in GA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 vs Sham in GA: Clinical Trial page.